Info: Zenodo’s user support line is staffed on regular business days between Dec 23 and Jan 5. Response times may be slightly longer than normal.

Published January 21, 2022 | Version v1
Journal article Open

Hypertrophic Cardiomyopathy, Sudden Death and Implantable Defibrillators

  • 1. PhD, Head of Department, Department of Pharmacology, Samarkand State Medical Institute
  • 2. Department of Pharmacology, Samarkand State Medical Institute
  • 3. Assistant, Department of Pharmacology, Samarkand State Medical Institute

Description

ABSTRACT: Implantable cardiac defibrillators (ICD) are greatly efficient in eliminating arrhythmias in patients withhigh-risk hypertrophic cardiomyopathy, showing that this equipment has a contribution in the prevention and treatment of unexpected death. When patients have risk marker, unexpected death in one or more first-degree relations with maximal left ventricle wall thickness 30 mm of current and unexplained syncopal episode, ICD installation is considered appropriate. If one has a dangerously fast heartbeat that prevents heart from pumping enough blood to the rest of body ventricular fibrillationor ventricular tachycardia, or if the patient is at high risk of suffering such a heart rhythm problem (arrhythmia), usually due to a weak heart muscle, the patient can survive using ICD.

Files

9rajar.pdf

Files (523.5 kB)

Name Size Download all
md5:76c42853aa807bf84ea3259c82ca8674
523.5 kB Preview Download